First Opinion By Tracey Wilkinson, Julie Maslowsky and Laura Lindberg A major problem for minors: post-Roe access to abortion
First Opinion By Cynthia A. Stuenkel and JoAnn E. Manson Are five decades of progress in women’s health in peril?
Health By Damian Garde Is sexual desire a medical issue? An experimental drug for women revives an intense debate
Politics By Lev Facher and Megan Thielking As the March for Life approaches, anti-abortion leaders are rebranding as ‘pro-science.’ Scientists say otherwise
Politics By Nicholas Florko A SCOTUS case on ‘cobra sexual energy’ supplements highlights FDA’s oversight of a growing industry
First Opinion By Nina Agrawal As a pediatrician, I work with sexually assaulted teens. They deserve full investigations
First Opinion By Melanie Thompson and Matthew Zahn Sexually transmitted infections are at an all-time high. Urgent action is needed
Health By Kate Sheridan Will insurers have to cover the controversial contraception app Natural Cycles under Obamacare’s mandate?
Biotech By Rebecca Robbins A women’s health startup tried to drum up interest for a much-needed drug. Many men didn’t get it
First Opinion By Doris Browne Trump administration’s proposed change to Title X endangers doctor-patient trust
First Opinion By Pamela Mahoney Tsigdinos As the dark side of IVF slowly comes into focus, even more transparency is needed
Health By Justin Chen Adherence to PrEP, the HIV prevention drug, is low. A new study suggests a pill with a tiny sensor might help
First Opinion By Régine Sitruk-Ware Getting contraceptives for men to the market will take pharma’s help
Business By Rebecca Robbins These are the most — and least — friendly states for a new wave of buzzy telemedicine startups
Business By Rebecca Robbins A startup promised to make health care ‘refreshingly simple.’ Building the business has been anything but
Health By Helen Branswell Antibiotics could dramatically reduce STIs, study says, raising tough new questions
First Opinion By Sabrina Johnson and Jessica Grossman The biotech industry needs to pay more attention to women’s health
First Opinion By Kimberly Zieselman In the intersex community, we’re desperate for quality care. Doctors aren’t listening